Close menu

December 21st, 2021 | 11:33 CET

HelloFresh, TeamViewer, CoinAnalyst: Shares for 2022?

  • crypto
Photo credits:

Tech stocks again lost significantly on Monday. The TecDAX was down 0.5% at 3,788 points in the late afternoon. As a result, this means that investors are still waiting in vain for the year-end rally. Uncertainty currently dominates the stock markets: on the further course of the Corona pandemic and the expected economic stimulus package in the United States. We look at three stocks that could have an excellent start to 2022. From the planned renewed restrictions on public life to the lockdown in Germany and numerous other countries, HelloFresh and TeamViewer should benefit. CoinAnalyst aims to make cryptocurrency trading easier with a new app in the first quarter of 2022.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: HELLOFRESH SE INH O.N. | DE000A161408 , TEAMVIEWER AG INH O.N. | DE000A2YN900 , CoinAnalyst Corp. | CA19260U1084

Table of contents:

    CoinAnalyst: New App for crypto trading

    Bitcoin is not offering a safe haven at the moment. The price of the digital gold has plummeted from around USD 59,000 to USD 46,000 in the past 30 days alone. Unfortunately, this includes companies that are active in the crypto universe. Among them are MicroStrategy in the US and the German Bitcoin Group. Still relatively unknown and new on the German price list is CoinAnalyst. The Company was listed on the Canadian CSE via reverse IPO but originally comes from Germany. CoinAnalyst specializes in Big Data analysis of cryptocurrencies. The Company's artificial intelligence (AI) is based on the proven technology of Cogia AG, which is also listed on the stock exchange. The AI sifts through 300 sources of information for coins, tokens and NFTs - and counting. The data is provided to customers on personalized dashboards. In addition to the products "Insights" and "Crypto Market Letter", which will appear globally in the future, the focus is primarily on the "Copy Trading" segment. In this product, investors follow trading experts and an AI-supported trading strategy. So far, a return of around 60% p.a. has been achieved. The area is to be significantly expanded. Among other things, through a smartphone app. The launch is planned for the first quarter of 2022. A crypto academy is also to be built.

    CoinAnalyst's growth plans are ambitious. After a turnover of CAD 0.9 million in the current year, the target is already CAD 17.09 million in 2023. If this rapid growth can be implemented as planned, the current market capitalization appears favorable. It currently stands at around CAD 11 million.

    HelloFresh: Analysts see a price potential of over 50%

    After Christmas, there will probably be contact restrictions in Germany. That indicates that COVID-19 will continue to be the dominant topic in early 2022. HelloFresh should benefit from this. The share was one of the big Corona winners but was punished significantly by investors in recent weeks. The reason for this was the disappointing outlook for 2022.

    Investors and analysts had expected more, especially in terms of adjusted EBITDA. Should there actually be significant restrictions again in the coming months - and everything looks like there will be - the shipper of cooking boxes should face a remarkable boom with positive effects on sales and earnings. Already in recent days, analysts had renewed their buy recommendations. Berenberg named a price target of EUR 106. The investments of the cooking box supplier are groundbreaking for more growth and profitability in the future, the analysts said. The strategy will pay off in the medium term. The colleagues at Jefferies are even more optimistic. The analysts of the US investment bank have slightly raised the price target for HelloFresh shares from EUR 109 to EUR 114 and confirmed their buy recommendation. The analysts do not believe that the adjusted operating margin (EBITDA) in the developed markets of around 20% should come under sustained pressure. In addition, HelloFresh will increasingly benefit from automation.

    TeamViewer: Revival of the "stay-at-home shares"?

    TeamViewer could also benefit from curfews, mandatory home offices, and lockdowns. And the stock is in desperate need of a little tailwind. The latest bad news was that TeamViewer shares had to leave the STOXX Europe 600. The same applies to the real estate company Grand City Properties and the online retailer of home supplies Zooplus.

    TeamViewer shares were among the biggest losers on the stock market this year. It lost more than 70% of its value and threatened to slip below the EUR 10 mark a few days ago. It is now trading at EUR 11.50. But for a sustained price recovery, management must first regain lost confidence, which was massively shaken after the controversial sponsorship deal with Manchester United and several profit warnings. However, the beginning of the COVID-19 pandemic showed just how quickly things can go up. It went up from EUR 25 to up to EUR 54 between March and July 2020. The share will certainly not reach this level again soon, but a countermovement towards EUR 20 cannot be ruled out in the event of a revival of the "stay-at-home shares".

    The Corona pandemic will be the dominant topic on the stock market in the coming weeks - and probably far beyond. HelloFresh and TeamViewer are two shares that could benefit from this. Bitcoin and cryptocurrencies are gaining more and more fans. Here, CoinAnalyst wants to make trading easier with a new app.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author

    Related comments:

    Commented by André Will-Laudien on March 11th, 2024 | 07:00 CET

    Bitcoin USD 70,000 - High-tech and artificial intelligence - a perennial favorite! Nvidia, Defense Metals, AMD and Super Micro Computer

    • Mining
    • RareEarths
    • hightech
    • AI
    • crypto

    It happened over the weekend: USD 70,000 - and no end in sight for Bitcoin? A never-ending rally seems to be taking its course after the cryptocurrency turned upwards at USD 25,000 last September. Will the upswing continue unabated? Due to the upcoming halving in April, this could continue for a few more weeks, with the crypto following growing daily. Suppliers in the high-tech sector are riding the same wave: fast computers, graphics cards, big data and artificial intelligence. Almost infinite growth is expected behind these megatrends. However, valuations are already very advanced. Where are the opportunities for newcomers now?


    Commented by Juliane Zielonka on March 1st, 2024 | 17:05 CET

    Cardiol Therapeutics, Bayer, Coinbase - Which share will generate profits in the long term?

    • Biotechnology
    • Pharma
    • crypto

    The world of pharmaceuticals and life sciences is characterized by precisely documented studies in clinical research. If an active ingredient makes it to approval, there is the potential for a blockbuster worth billions. Cardiol Therapeutics has an active ingredient in the second phase of clinical research for the treatment of heart disease in people under 35 years of age. This active ingredient can also restore the quality of life of 26 million people worldwide who suffer from heart failure. Bayer continues to clean up the unresolved issues left behind by the former CEO. Did the weedkiller RoundUp® from the Monsanto deal possibly lead to improper treatment due to a lack of consumer protection information? The five-figure lawsuits still pending against Roundup are dampening the share's profit prospects. The situation is currently quite different in the cryptocurrency market. Bitcoin is outperforming everyone, and the Coinbase share is benefiting from it. Which investment generates profits in the long term?


    Commented by Juliane Zielonka on February 29th, 2024 | 08:15 CET

    Defense Metals, Coinbase, Volkswagen: Critical metals for pioneering technologies

    • Mining
    • RareEarths
    • crypto
    • AI
    • Electromobility

    The demand for critical metals is increasing rapidly worldwide. From growing digitalization to the increased use of cryptocurrencies and AI, from advances in medical technology to electromobility and defense technology - all these areas rely on these critical raw materials. Defense Metals Corporation is an experienced explorer in British Columbia whose Wicheeda project is designed to provide these critical metals. Forward-thinking companies like the crypto exchange Coinbase serve many users who use rare earth metals to power their hard drives for crypto mining. Volkswagen also requires this raw material because car consumers in China have very different needs when it comes to vehicle software than those in the European market. A new CEO for the subsidiary and software company CARIAD knows exactly what needs to be done...